Bing Yan Email

Co-Founder & CMO . AnHeart Therapeutics

Shanghai, NY

Location

LinkedIn

Current Roles

Employees:
46
Revenue:
$7.1M
About
AnHeart Therapeutics is an oncology-focused clinical stage biopharmaceutical company headquartered in Hangzhou, China with offices in Beijing, Shanghai and New York. The company’s pipeline consists of three clinical stage assets: Taletrectinib, a next-gen ROS1 and NTRK inhibitor currently in Phase 2; an mIDH1 inhibitor ready for Phase 2 for low grade glioma, cholangiocarcinoma, AML and other tumors; and an AXL inhibitor in Phase 1 for overcoming resistance in various tumors.
AnHeart Therapeutics Address
777 Third Avenue
Shanghai, NY
United States
AnHeart Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.